SEC Form 4 · accession 0000899243-16-027583
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anne Vanlent
Director
Period of report
Aug 17, 2016
Accepted (ET)
Aug 18, 2016 · 5:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $15.13 | Aug 17, 2016 | A | 16,000 | A | — | Aug 17, 2026 | Common Stock | 16,000 | 16,000 | D |
Explanation of responses
- F1Option becomes exercisable in equal yearly installments over three years from the date of grant.